1. Home
  2. CMRE vs CRVS Comparison

CMRE vs CRVS Comparison

Compare CMRE & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$17.19

Market Cap

1.8B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$16.57

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
CRVS
Founded
1974
2014
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
CMRE
CRVS
Price
$17.19
$16.57
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$28.00
AVG Volume (30 Days)
462.9K
2.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.63
$2.54
52 Week High
$17.52
$26.95

Technical Indicators

Market Signals
Indicator
CMRE
CRVS
Relative Strength Index (RSI) 56.04 48.45
Support Level $16.62 $17.27
Resistance Level $17.52 $19.98
Average True Range (ATR) 0.63 1.29
MACD 0.04 -0.83
Stochastic Oscillator 68.05 0.00

Price Performance

Historical Comparison
CMRE
CRVS

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: